Ximbio is pleased to be attending the annual EuroMAbNet meeting in September 2015.
EuroMAbNet represents the first European network of laboratories linked to academic Institutions, each having an internationally recognized reputation in the production of monoclonal antibodies. The current President Dr Giovanna Roncador and Vice President Prof Alison Banham are both among the group’s founder members. EuroMAbNet spans 11 European countries and members possess a wealth of expertise in monoclonal antibody technology, ranging from identification and production of immunogens, the production of fully validated antibodies and their use as research tools, diagnostic/prognostic reagents and therapeutics.
EuroMAbNet meetings take place annually and provide a forum for a variety of topics to be discussed. These range from developing strategies in accurate antibody validation and discussion around cutting edge methodology in antibody production and technology. A recent aim of the EuroMAbNet is to proactively promote strategies for antibody validation to combat poorly characterised reagents perpetuating reproducibility issues in scientific studies. EuroMAbNet article and guidelines are available in the EuroMAbNet webpage (http://www.euromabnet.com/guidelines/ ) be invaluable to researchers by providing them with tools to identify and validate antibodies from other sources.
We have a slot to present to the EuroMAbNet group about the benefit of sharing research reagents through Ximbio our mission to be integral to researcher in sharing knowledge and trading reagents.